Kit: Central Line Dres Change 20/Cs

FDA Device Recall #Z-0147-2022 — Class II — September 8, 2021

Recall Summary

Recall Number Z-0147-2022
Classification Class II — Moderate risk
Date Initiated September 8, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Medical Action Industries, Inc. 306
Location Arden, NC
Product Type Devices
Quantity 42 cases

Product Description

Kit: Central Line Dres Change 20/Cs

Reason for Recall

The ChloraPrep 3ml kit component has a shorter expiry date than the labeled kit expiry date.

Distribution Pattern

Distribution to a single US distributor in Michigan

Lot / Code Information

Product Code: 59815B, Batch 0000285665; Kit expiration date 03/31/2024 UDI: 20809160170523

Other Recalls from Medical Action Industries, Inc. 306

Recall # Classification Product Date
Z-3129-2024 Class II Foam Protective Pouches, model numbers 6010 (50... Jun 11, 2024
Z-1394-2024 Class II IV Start Kit, containing 1 Saline Syringe 5ml, ... Jan 15, 2024
Z-0751-2023 Class II Medical Action INDUSTRIES INC. Port a Cath Kit ... Nov 4, 2022
Z-0464-2023 Class II Medical Action Industries Inc. Port Access Kit,... Oct 12, 2022
Z-0765-2023 Class II Medical Action Industries Inc. Disposable Instr... Oct 12, 2022

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.